Novel Therapeutic Approach for Human T-cell Malignancies
Recruiting
Observational Study
T-Cell Leukemia/Lymphoma, Adult
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 120 (estimated)
- Sponsor
- Istituto Oncologico Veneto IRCCS · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This multicenter translational study, with prospective and retrospective samples, aims to identify new strategies to selectively eliminate neoplastic T cells by modulating intracellular ROS levels.
Interactions between drugs capable of activating the apoptotic process (e.g., Venetoclax) and drugs capable of altering ROS homeostasis (e.g., inhibitors of the enzyme glucose-6-phosphate dehydrogenase…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with pre- and post-thymic T-cell leukemia/lymphoma
* Patients of both sexes
* Age of patients older than 18 years
* Patient is willing to provide written and signed informed consent for participation in the study
Exclusion Criteria:
-Serious illness or medical condi…
Contacts